Preoperative Surgical Preparation: Fasting Protocols, Pre-Anesthesia Clearance, and Medication Hold Guidelines

Modern Preoperative Fasting Guidelines (NPO Status)

For decades, the historical standard of 'NPO after midnight' (nothing by mouth) subjected patients to unnecessary dehydration, hypovolemia, nausea, and insulin resistance. The contemporary American Society of Anesthesiologists (ASA) evidence-based fasting practice guidelines provide a nuanced, safe schedule designed to minimize gastric volume and acidity while preventing metabolic distress:

1. Clear Liquids (water, black coffee without milk, clear fruit juice without pulp, electrolyte drinks): Permitted up to 2 hours prior to procedural sedation or general anesthesia induction. In fact, preoperative complex carbohydrate drinks ingested 2 hours preoperatively reduce postoperative insulin resistance and shorten hospital length of stay in Enhanced Recovery After Surgery (ERAS) pathways. 2. Light Meal (toast and clear liquids) or Infant Formula: Permitted up to 6 hours prior to induction. 3. Heavy, Fatty, or Fried Meals and Meat: Require at least 8 hours of complete gastric emptying time.

Adherence to these fasting rules prevents pulmonary aspiration of gastric contents—a catastrophic anesthetic complication where acidic gastric fluid enters the tracheobronchial tree, producing acute chemical pneumonitis (Mendelson's syndrome) and severe respiratory failure.

Cardiovascular and Pulmonary Risk Stratification

Elective surgery introduces significant physiological stress, characterized by sympathetic activation, hypercoagulability, and fluctuating hemodynamic loading conditions. Preoperative evaluation establishes the patient's functional capacity, traditionally measured in Metabolic Equivalents (METs). An individual unable to climb two flights of stairs or walk briskly without severe dyspnea (<4 METs) is at elevated risk for perioperative myocardial infarction.

The Revised Cardiac Risk Index (RCRI, or Lee Index) evaluates six independent clinical variables: high-risk surgical procedure (intraperitoneal, intrathoracic, or suprainguinal vascular), history of ischemic heart disease, history of congestive heart failure, history of cerebrovascular disease, preoperative insulin therapy, and preoperative serum creatinine >2.0 mg/dL. Patients with an RCRI score ≥2 or poor functional capacity undergoing high-risk vascular procedures warrant formal cardiology consultation, echocardiography, or pharmacologic stress testing.

Perioperative Medication Management: What to Continue and What to Hold

Managing chronic prescription medications leading up to surgery requires meticulous multidisciplinary coordination between primary care physicians, surgeons, and anesthesiologists:

- Medications to CONTINUE on the morning of surgery with a tiny sip of water: Beta-blockers (abrupt cessation triggers dangerous rebound tachycardia and ischemia), statins, most antiarrhythmics, chronic acid-suppressing PPIs, and thyroid hormone replacements. - Medications to HOLD: 1. ACE Inhibitors and ARBs: Usually held 24 hours prior to surgery to avert severe refractory 'vasoplegic' hypotension under general anesthesia. 2. Oral Antidiabetic Drugs: Metformin is held on the day of surgery to reduce lactic acidosis risks. SGLT2 inhibitors (empagliflozin, dapagliflozin) must be held 3 to 4 days prior to surgery due to prolonged pharmacodynamic suppression of renal glucose reabsorption and risk of life-threatening euglycemic DKA. 3. Anticoagulants and Antiplatelets: Warfarin is held 5 days preoperatively with INR verified ≤1.4; Direct Oral Anticoagulants (DOACs like apixaban, rivaroxaban) are held 24 to 72 hours based on procedural bleeding risk and creatinine clearance. Clopidogrel is typically held 5 to 7 days, unless the patient has a recently placed drug-eluting coronary stent.

The Pre-Anesthesia Interview and ASA Physical Status

During the formal pre-anesthesia clinic visit, the anesthesia care team assesses the patient's airway using the Mallampati classification, thyromental distance, and cervical spine mobility to anticipate difficult endotracheal intubation. Personal and familial history of adverse anesthetic events—such as Malignant Hyperthermia (a rare, inherited pharmacogenetic hypermetabolic crisis triggered by volatile inhalational agents or succinylcholine) or Pseudocholinesterase deficiency—is rigorously explored.

Patients are assigned an ASA Physical Status Classification: - ASA I: Normal healthy patient. - ASA II: Patient with mild systemic disease without functional limitation (e.g., well-controlled hypertension, uncomplicated diabetes, mild obesity). - ASA III: Patient with severe systemic disease with functional limitation (e.g., poorly controlled diabetes, stable angina, COPD). - ASA IV: Patient with severe systemic disease that is a constant threat to life (e.g., recent MI, unstable angina, end-stage renal failure). - ASA V: Moribund patient not expected to survive without the operation.